Office of Research & Development |
![]() ![]() |
Project Number: | I01BX001444-05A1 |
Title: | Vaccinating at Mucosal Surfaces with Nanoparticle Conjugated Antigen and Adjuvant |
Principal Investigator: | Sebastian Joyce |
Location: | Nashville, TN |
Congressional District Code: | 5 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | April 2018 - March 2022 |
FY 2021 Funding Amount: | $156,800 |
Total Award Amount (all years): |
$892,406 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: The incidence of tuberculosis (TB) has increased among the Veterans in recent years because the global burden of TB is enormous. This burden has escalated with the emergence of multidrug-resistant and extremely drug resistant Mycobacterium tuberculosis (Mtb) strains and because current vaccines do not elicit long-lasting protective immunity against TB especially in adults. Hence, the development of new generations of vaccines that will confer durable protection against TB will significantly impr... |